Hussain M A, DiLuccio R C, Maurin M B
DuPont Merck Pharmaceutical Company, Pharmacy R&D, Wilmington, DE 19880-0400.
J Pharm Sci. 1993 Jan;82(1):77-9. doi: 10.1002/jps.2600820117.
The solubility of the antiarrhythmic drug moricizine at physiologic pH is very low. Precipitation after rapid intravenous injection of the hydrochloride salt of moricizine could be a concern. The enhancement of solubility of moricizine near physiologic pH via complexation with nicotinamide was examined as a potential solubilization technique. The studies were performed in pH 6 and pH 7 phosphate buffers at 25 degrees C by the phase solubility method. Moricizine formed 1:1 and 1:2 complexes with nicotinamide at pHs of 6 and 7. The complexation constants K1:1 and K1:2 were estimated by a previously described scheme and equation and compared with those obtained by fitting a line and a parabola to the equations derived from the scheme for both the approximate and exact solutions. The data were best represented by a parabolic regression analysis of the exact solution of the derived equation with values for K1:1 and K1:2 at pH 6 of 16.60 and 0.93 M-1, respectively, and at pH 7 of 7.70 and 5.41 M-1, respectively.
抗心律失常药物莫雷西嗪在生理pH值下的溶解度非常低。快速静脉注射莫雷西嗪盐酸盐后可能出现沉淀,这是一个需要关注的问题。通过与烟酰胺络合来提高莫雷西嗪在生理pH值附近的溶解度作为一种潜在的增溶技术进行了研究。这些研究在25℃的pH 6和pH 7磷酸盐缓冲液中采用相溶解度法进行。在pH 6和pH 7时,莫雷西嗪与烟酰胺形成1:1和1:2的络合物。络合常数K1:1和K1:2通过先前描述的方案和方程进行估算,并与通过对从该方案导出的方程拟合直线和抛物线以获得近似解和精确解所得到的常数进行比较。数据通过对导出方程的精确解进行抛物线回归分析得到最佳表示,在pH 6时K1:1和K1:2的值分别为16.60和0.93 M-1,在pH 7时分别为7.70和5.41 M-1。